InMed Launches THCV, Expanding its Portfolio of Rare Cannabinoids for the Health and Wellness Sector Jun 9, 2022
InMed to Supply Rare Cannabinoids to Radicle Science’s “Radicle Energy Study” to Assess the Health Effects of THCV May 5, 2022
MariMed Completes Acquisition of Kind Therapeutics USA, a Maryland Vertically Integrated Cannabis Business Apr 28, 2022